NCT07372625 2026-03-12A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.PMV Pharmaceuticals, IncPhase 1 Recruiting14 enrolled